Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancer.
European journal of cancer (Oxford, England : 1990)(2023)
摘要
ClinicalTrials.gov: NCT02291289.
更多查看译文
关键词
BRAF,Biomarkers,Cetuximab,Colorectal cancer,HER2,Maintenance therapy,Vemurafenib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要